Some challenged claims of Masimo Corp.'s patent that relates to a multi-parameter patient monitor capable of displaying multiple patient parameters in various display modes are unpatentable as obvious over prior art, the Patent Trial and Appeal Board said, in an inter partes review by Apple Inc. The board determined that the challenged claims are obvious over various combinations of prior art, including prior art that relates to a flexible healthcare management system for managing and risk stratifying of patients, to a GUI for a patient monitoring system, and to a patient monitoring system with a configurable GUI that provides summary ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.